263 related articles for article (PubMed ID: 1415186)
1. 5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells.
Bottomley SS; Healy HM; Brandenburg MA; May BK
Am J Hematol; 1992 Oct; 41(2):76-83. PubMed ID: 1415186
[TBL] [Abstract][Full Text] [Related]
2. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
[TBL] [Abstract][Full Text] [Related]
3. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene.
Furuyama K; Fujita H; Nagai T; Yomogida K; Munakata H; Kondo M; Kimura A; Kuramoto A; Hayashi N; Yamamoto M
Blood; 1997 Jul; 90(2):822-30. PubMed ID: 9226183
[TBL] [Abstract][Full Text] [Related]
4. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
[TBL] [Abstract][Full Text] [Related]
5. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
[TBL] [Abstract][Full Text] [Related]
6. Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia.
Furuyama K; Sassa S
J Clin Invest; 2000 Mar; 105(6):757-64. PubMed ID: 10727444
[TBL] [Abstract][Full Text] [Related]
7. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
May BK; Bhasker CR; Bawden MJ; Cox TC
Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
[TBL] [Abstract][Full Text] [Related]
8. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
9. Animal models for X-linked sideroblastic anemia.
Yamamoto M; Nakajima O
Int J Hematol; 2000 Aug; 72(2):157-64. PubMed ID: 11039663
[TBL] [Abstract][Full Text] [Related]
10. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
Ferreira GC
J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
[TBL] [Abstract][Full Text] [Related]
11. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation of the erythroid-specific gamma-Aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia.
Harigae H; Furuyama K; Kudo K; Hayashi N; Yamamoto M; Sassa S; Sasaki T
Am J Hematol; 1999 Oct; 62(2):112-4. PubMed ID: 10577279
[TBL] [Abstract][Full Text] [Related]
13. R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity.
Furuyama K; Uno R; Urabe A; Hayashi N; Fujita H; Kondo M; Sassa S; Yamamoto M
Br J Haematol; 1998 Dec; 103(3):839-41. PubMed ID: 9858242
[TBL] [Abstract][Full Text] [Related]
14. Multiple mechanisms for hereditary sideroblastic anemia.
Furuyama K; Sassa S
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):5-10. PubMed ID: 11929048
[TBL] [Abstract][Full Text] [Related]
15. Regulation of heme metabolism in normal and sideroblastic bone marrow cells in culture.
Ibraham NG; Lutton JD; Hoffman R; Levere RD
J Lab Clin Med; 1985 May; 105(5):593-600. PubMed ID: 3989352
[TBL] [Abstract][Full Text] [Related]
16. Haem synthesis in sideroblastic anaemia.
Konopka L; Hoffbrand AV
Br J Haematol; 1979 May; 42(1):73-83. PubMed ID: 465361
[TBL] [Abstract][Full Text] [Related]
17. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis.
Sadlon TJ; Dell'Oso T; Surinya KH; May BK
Int J Biochem Cell Biol; 1999 Oct; 31(10):1153-67. PubMed ID: 10582344
[TBL] [Abstract][Full Text] [Related]
18. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA.
Cox TC; Bawden MJ; Martin A; May BK
EMBO J; 1991 Jul; 10(7):1891-902. PubMed ID: 2050125
[TBL] [Abstract][Full Text] [Related]
19. [Progress of study on sideroblastic anemia and its possible gene therapy--review].
Wang YQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):524-8. PubMed ID: 15972158
[TBL] [Abstract][Full Text] [Related]
20. Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene.
Harigae H; Suwabe N; Weinstock PH; Nagai M; Fujita H; Yamamoto M; Sassa S
Blood; 1998 Feb; 91(3):798-805. PubMed ID: 9446639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
